Facebook
Twitter
LinkedIn
ForwardThe 12th Annual Diabetes Symposium of Wisconsin
Our symposium is a two day program with the specific purpose of increasing education and knowledge of all aspects of diabetes clinical practice and research. This symposium consists of medical lectures and workshops given by healthcare professionals (not all MD's), investigators and patients on topics related to Diabetes Updates. The major format used is a series of thematic talks by recognized health professional and are all followed by question and answer sessions along with feedback. There will also be a panel of physicians who will present case discussions and then open the floor to the audience for a Question and Answer Session.
Target Audience
Physicians, Family Care Physicians,
Adult Endocrinologists, Pediatric Endocrinologists, Fellows,
Residents, Medical Students, Dietitians, Physician Assistants,
Nurses and Nurse Practitioners
The target audience has been identified not only from the educational aims,
but also from the previous meetings after post-meeting evaluations.
Learning Objectives
- Improve diabetes and obesity care by identifying and expounding evidence-based advances in management.
- Analyze the areas that are at the outer limits of current knowledge of diabetes and obesity and define our limitations.
- Improve management and knowledge of drugs and therapy for diabetes and obesity, using well-controlled trial data.
- Gain further knowledge about the pathophysiological processes involved in diabetes and obesity.
- Increase awareness of the patient perspective of diabetes and obesity care.
Thursday, May 16th, 2019
7:00 am - 8:00 am Registration and Lite Breakfast
8:00 am - 8:05 am Introduction/Welcome
8:05 am - 8:40 am Adrian Vella, MD, FRCP (Edin.) - How the Pathophysiology of Type 2 Diabetes informs its treatment
8:40 am - 9:15 am Carlos Mendez, MD, FACP - Insulin Based Diabetes Therapies
9:15 am - 9:50 am Srividya Kidambi, MD, MS - Novel non-Insulin Therapies for Type 2 Diabetes
9:50 am - 10:05 am Break
10:05 am - 10:25 am Q & A: Case Discussion and Audience Response Session
10:25 am - 11:00 am Rochelle Naylor, MD - Recognition, Diagnosis and Management of Monogenic Diabetes
11:00 am - 11:55 am David D'Alessio, MD - Management of Hyperglycemia in Type 2 Diabetes: Consensus guidelines from the ADA and EASD
11:55 am - 12:30 pm Lisa Neff, MD, MS - Dietary Modification in the Treatment of Type 2 Diabetes
12:30 pm - 1:15 pm Lunch
1:15 pm - 1:50 pm Steven Magill, MD, PhD - Novel Diabetes Technology Part 1
1:50 pm - 2:25 pm Erin Newkirk, PharmD, CDE - Novel Diabetes Technologies - Part 2
2:25 pm - 3:00 pm Joseph Shaker, MD - The Skeleton in Diabetes
3:00 pm - 3:15 pm Break
3:15 pm - 3:35 pm Q & A: Case Discussion and Audience Response Session
3:35 pm - 4:10 pm Rosanna Fiallo-Scharer, MD & Maggie Frederick, RN, BSN - Transitioning patients with Type 1 Diabetes to adult care: Review of the evidence and CHW Transition program
4:10 pm - 4:45 pm Dawn Belt Davis, MD, PhD - Novel Discoveries in the Pathogenesis of Type 1 Diabetes
Friday, May 17th, 2019
7:00 am - 8:00 am Registration and Lite Breakfast
8:00 am - 8:05 am Introduction/Welcome
8:05 am - 8:40 am Thomas Connor, MD - Diabetic Retinopathy 2019 - How together we make a difference in combatting Blindness
8:40 am - 9:15 am Steven Magill, MD, PhD - The Year in Review in Diabetes, 2018-2019
9:15 am - 9:50 am Tammy Kindel, MD, PhD - Metabolic Surgery for the Treatment of Diabetes
9:50 am - 10:05 am Break
10:05 am - 10:25 am Q & A: Case Discussion and Audience Response Session
10:25 am - 11:00 am Larry Miller, PsyD - A Psychosocial 3D View of Patient with Diabetes
11:00 am - 11:35 am Jennifer Heinemann, PhD - Motivational Interviewing - Motivate your Patients to change Health Behaviors
11:35 am - 12:10 pm Kate Glasenapp, DNP, APRN, BC-ADM, CDE, CBN - Shared Medical Appointments: Exploring a Care Delivery Model in Metabolic Health
12:10 pm - 12:55 pm Lunch
12:55 pm - 1:15 pm Q & A: Case Discussion and Audience Response Session
1:15 pm - 1:50 pm Juan Figueroa, MD - Diabetic Neuropathy - Pathogenesis and Treatment
1:50 pm - 2:25 pm Paul Knudson, MD - Secondary causes of Diabetes Mellitus
2:25 pm - 3:00 pm Janet Williams, MA - Diabetes Care Begins with Diabetes Prevention
In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Thomas B. Connor, Jr., MD (Speaker)
- Alan K. David, MD (Panning Committee)
- Dawn Belt Davis, MD, PhD (Speaker)
- Leonard E. Egede, MD, MS (Planning Committee)
- Rosanna Fiallo-Scharer, MD (Planning Committee & Speaker)
- Juan J. Figueroa, MD (Speaker)
- Maggie Frederick, RN, BSN (Speaker)
- Gina George, PA-C (Planning Committee)
- Kate Glasenapp, DNP, APRN, BC-ADM, CDE, CBN (Planning Committee & Speaker)
- Susan Hjelsand (Planning Committee)
- Srividya Kidambi, MD, MS (Activity Director & Speaker)
- Tammy Lynn Kindel, MD, PhD (Speaker)
- Paul Knudson, MD (Speaker)
- Steven B. Magill, MD, PhD (Planning Committee & Speaker)
- Lawrence A. Miller, PsyD (Speaker)
- Rochelle Naylor, MD (Speaker)
- Lisa M. Neff, MD, MS (Speaker)
- Erin Newkirk, PharmD, CDE (Speaker)
- Daisy Sahoo, PhD, FAHA (Planning Committee)
- Janet Williams, MA (Speaker)
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved:
| Name | Company | Role |
|---|---|---|
| David D'Alessio, MD | Eli Lilly Co. | Consulting Fee |
| David D'Alessio, MD | Eli Lilly Co. & Merck | Research Grant |
| Jennifer Heinemann, PhD | Marquette University | Guest Speaker |
| Carlos Mendez, MD, FACP | Monarch Medical Technologies | Advisory Board |
| Joseph Shaker, MD | McGraw-Hill | Case Writer |
| Adrian Vella, MD, FRCP (Edin) | Novo Nordisk | Investigator |
| Adrian Vella, MD, FRCP (Edin) | vTv Therapeutics | Consultant |
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 13.25 hours of participation for continuing education for allied health professionals.
Available Credit
- 13.25 AAFPAAFP credit.
- 13.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 13.25 Hours of ParticipationHours of Participation credit.
Price
All registrations will be assessed an $8.60 non-refundable processing fee.
| Physicians (full course) | $215.00 |
| Allied Health Care Professionals (full course) | $215.00 |
| Residents/Fellows/Students* (full course) | $215.00 |
| Thursday Only | $125.00 |
| Friday Only | $125.00 |
Please note! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover.
*Residents, Fellows, Students of the Medical College of Wisconsin may attend this conference at no cost however, on-line registration is required.To obtain your complementary registration fee instructions contact Debby Warpechowski at 414-955-6724 or via email at dwarpech@mcw.edu prior to registering on-line.
Refund Policy:
Cancelations dated seven or more business days prior to the start of the course will be refunded. Cancellations received less than seven days before the course will be refunded at 50%. Cancellations received after the course begins will not be refunded. In the unlikely event the symposium is cancelled, the Medical College of Wisconsin is not responsible for airfare, hotel or other costs incurred by participants.